Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOT-3010 vs Humira in moderate-to-severe plaque psoriasis
CTR20211883Phase 3Completed
- Sponsor
- Shanghai Hile Bio-Technology
- Start
- Jul 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in psoriasis, sponsored by Shanghai Hile Bio-Technology. Started Jul 2021; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20211883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211883.